Clinical trial Recruiting at 1 site Interventional Ages 3 to 17

Intensive upper-limb rehabilitation program for children and teenagers with cerebral palsy

Official title: Effect of an Intensive Rehabilitation Protocol Combining Constraint-Induced Movement Therapy and Bimanual Training on Upper Limb Use and Gross Motor Function in Children and Adolescents With Cerebral Palsy

Run by Fondation Ellen Poidatz · NCT07285837 · Data updated 2026-11-12

This program tries two intensive therapies—constraint-induced movement therapy and bimanual intensive therapy—to improve arm and hand use in children and adolescents with cerebral palsy.

More Cerebral Palsy (CP) trials

Quick facts

Study typeInterventional
Ages3 Years to 17 Years
SexAll
Enrollment90 (estimated)
SponsorFondation Ellen Poidatz
Academic / other
Locations1 site (Saint-Fargeau-Ponthierry, Île-de-France Region)
StatusRecruiting
StartedNovember 21, 2025
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedJanuary 29, 2026
Trial IDNCT07285837 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 3–17 with a clinical diagnosis of cerebral palsy, GMFCS and MACS levels I–IV, able to cooperate with instructions and covered by the French social security system are ideal candidates.

Probably not a fit

Patients with injuries or pain preventing participation, significant behavioral disorders, or those who had botulinum toxin injections or surgery within the past six months are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program delivers concentrated upper-limb rehabilitation using two established approaches: Constraint-Induced Movement Therapy (CIMT), which restricts the unaffected limb to encourage use of the affected limb, and Bimanual Intensive Therapy (BIT), which trains both hands together to improve coordination. Eligible participants are children and adolescents aged 3–17 with CP and GMFCS/MACS levels I–IV who can follow simple instructions. Treatment occurs at the Fondation Ellen Poidatz in Saint-Fargeau-Ponthierry and excludes those with recent surgery or botulinum toxin injections, significant pain, or behavioral disorders. The protocol aims to maximize functional gains through short-term intensive training rather than standard, lower-frequency rehabilitation.

Why it matters

Potential benefit: If successful, the program could increase hand and arm function and improve independence in daily activities for participating children.

How similar studies have gone: Previous studies have shown that both CIMT and BIT can improve upper-limb function in children with cerebral palsy, so this program applies established intensive rehabilitation approaches rather than an entirely novel therapy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A clinical diagnosis of CP mentioned in the medical record
* Aged between 3 and 17 years inclusive (\<18 years)
* Global Motor Function Classification System (GMFCS) and Manual Ability Classification System (MACS) levels I to IV
* Ability to cooperate, understand and follow simple instructions
* Patient affiliated to the French social security system
* Voluntary patient whose parents have given their consent for their child to participate in the study.

Exclusion Criteria:

* Presence of injuries incompatible with participation in the program, or pain rated \>3 on the Visual Analogue Scale (VAS)
* Presence of behavioral disorders
* History of botulinum toxin injections or surgical intervention within six months prior to study enrollment.

Where it's running

  • Fondation Ellen Poidatz
    Saint-Fargeau-Ponthierry, Île-de-France Region, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.